Yayın:
Pharmacokinetics and Bioavailability of Carprofen in Rainbow Trout (Oncorhynchus mykiss) Broodstock

dc.contributor.authorUney, Kamil
dc.contributor.authorDurna Corum, Duygu
dc.contributor.authorTerzi, Ertugrul
dc.contributor.authorCorum, Orhan
dc.date.accessioned2026-01-04T15:31:10Z
dc.date.issued2021-06-30
dc.description.abstractThe aim of this study was to determine the pharmacokinetics of carprofen following intravenous (IV), intramuscular (IM) and oral routes to rainbow trout (Oncorhynchus mykiss) broodstock at temperatures of 10 ± 1.5 °C. In this study, thirty-six healthy rainbow trout broodstock (body weight, 1.45 ± 0.30 kg) were used. The plasma concentrations of carprofen were determined using high-performance liquid chromatography and pharmacokinetic parameters were calculated using non-compartmental analysis. Carprofen was measured up to 192 h for IV route and 240 h for IM, and oral routes in plasma. The elimination half-life (t1/2λz) was 30.66, 46.11, and 41.08 h for IV, IM and oral routes, respectively. Carprofen for the IV route showed the total clearance of 0.02 L/h/kg and volume of distribution at steady state of 0.60 L/kg. For IM and oral routes, the peak plasma concentration (Cmax) was 3.96 and 2.52 μg/mL with the time to reach Cmax of 2 and 4 h, respectively. The bioavailability was 121.89% for IM route and 78.66% for oral route. The favorable pharmacokinetic properties such as the good bioavailability and long t1/2λz for IM and oral route of carprofen suggest the possibility of its effective use for the treatment of various conditions in broodstock.
dc.description.urihttps://doi.org/10.3390/pharmaceutics13070990
dc.description.urihttps://www.mdpi.com/1999-4923/13/7/990/pdf
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/34208822
dc.description.urihttp://dx.doi.org/10.3390/pharmaceutics13070990
dc.description.urihttps://doaj.org/article/99c3155447f44c95a8de3314d5384072
dc.description.urihttps://dx.doi.org/10.3390/pharmaceutics13070990
dc.identifier.doi10.3390/pharmaceutics13070990
dc.identifier.eissn1999-4923
dc.identifier.openairedoi_dedup___::187d25ecec539fb3c397564d75137ad8
dc.identifier.orcid0000-0002-8674-4873
dc.identifier.orcid0000-0003-1567-991x
dc.identifier.orcid0000-0003-2811-6497
dc.identifier.orcid0000-0003-3168-2510
dc.identifier.pubmed34208822
dc.identifier.scopus2-s2.0-85109515725
dc.identifier.startpage990
dc.identifier.urihttps://hdl.handle.net/20.500.12597/38880
dc.identifier.volume13
dc.identifier.wos000676782300001
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.ispartofPharmaceutics
dc.rightsOPEN
dc.subjectRS1-441
dc.subjectcarprofen
dc.subjectPharmacy and materia medica
dc.subjectbroodstock
dc.subjectbioavailability
dc.subjectpharmacokinetics
dc.subjectrainbow trout
dc.subjectArticle
dc.subject.sdg3. Good health
dc.titlePharmacokinetics and Bioavailability of Carprofen in Rainbow Trout (Oncorhynchus mykiss) Broodstock
dc.typeArticle
dspace.entity.typePublication
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar